Tag: MRI
Low rate of new white lesions detected after TCAR using diffusion-weighted...
New white lesions are not a common occurrence in patients who have undergone transcarotid artery revascularisation (TCAR), a study in which patients were assessed...
AiM Medical Robotics raises US$3.4 million to accelerate MRI-compatible robotics platform
AiM Medical Robotics recently announced that it has raised US$3.4 million in seed funding, led by IQ Capital and Surrey Capital Partners. Other investors include The...
Abbott announces expanded MRI compatibility for Proclaim XR spinal cord stimulation...
Abbott has announced that the US Food and Drug Administration (FDA) has approved new, expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR spinal cord...
White matter hyperintensities may hold key to identifying long-term harm in...
A new study has found that brain scans taken during the lifetimes of athletes in contact sports, compared to changes in their brains at...
Indian health ministry approves Exablate Neuro focused ultrasound platform
Insightec has announced its incisionless neurosurgery platform, the Exablate 4000, has received market approval by the Central Drugs Standard Control Organization (CDSCO)—part of the Ministry...
SyntheticMR and Siemens Healthineers extend collaboration with new license agreement
SyntheticMR has entered a general software license agreement for distribution with Siemens Healthineers. The agreement enables Siemens Healthineers to market, sell and distribute SyntheticMR's...
SpinTech earns FDA clearance for rapid, quantitative brain-imaging technology
The US Food and Drug Administration (FDA) has granted 510(k) approval for STAGE (Strategically acquired gradient echo), the latest magnetic resonance imaging (MRI) technology...
Revolution in neurotherapy? Spotlight on focused ultrasound at 2021 EAN congress
While focused ultrasound is by no means a brand-new innovation in the field of neurotherapy—having first been deployed in the 1950s, if not earlier,...
Neuro42 closes US$6.5 million Series A financing round
Neuro42, a US medical technology start-up focused on magnetic resonance imaging (MRI) and robotics, has announced the close of a US$6.5 million Series A...
Axonics receives FDA approval for 3T full-body MRI scans
Axonics, a company that has developed and is commercialising novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, has...
FDA approval for Axonics’ wireless patient Remote Control with SmartMRI technology
Axonics, a company that has developed implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, has announced US Food and...
Portable MRIs bring diagnostics to stroke patients’ bedside
A portable, low-field magnetic resonance imaging (MRI) system may become a safe and practical way to get accurate brain images at a patient’s bedside,...
Medtronic receives CE mark for InterStim Micro Neurostimulator and InterStim SureScan...
Medtronic has announced it has received CE mark for its InterStim Micro neurostimulator and InterStim SureScan MRI leads—clearing the technologies for commercial sale and...
Medtronic announces FDA submission for InterStim Micro neurostimulator and SureScanTM MRI...
Medtronic announces it has filed a premarket approval (PMA) supplement with the US Food and Drug Administration (FDA) for approval of its InterStim Micro...
Axonics announces FDA approval for the use of full-body MRI for...
Axonics have announced that the Food & Drug Administration (FDA) approved the use of full-body magnetic resonance imaging (MRI) using 1.5 Tesla MRI scanners...
InSightec receives CE Mark for Exablate Neuro for Siemens Healthineers MRI...
New magnetic resonance imaging (MRI) compatibility holds potential to expand patient access around the world to incisionless brain surgery. Siemens Healthineers and InSightec have...
Eye could provide “window to the brain” after stroke
Research into curious bright spots in the eyes on stroke patients’ brain images could one day alter the way these individuals are assessed and...
Nevro receives CE mark for full-body MRI conditional labelling with the...
Nevro has received the CE mark for full-body magnetic resonance imaging (MRI) conditional labelling on the Senza Spinal Cord Stimulation (SCS) System delivering HF10...
FDA clears first 7T magnetic resonance imaging device
The US Food and Drug Administration has cleared the first seven tesla (7T) magnetic resonance imaging (MRI) device, more than doubling the static magnetic...
First neonatal magnetic resonance imaging device cleared by US FDA
The US Food and Drug Administration (FDA) has cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in...
LivaNova’s VNS Therapy receives FDA approval for expanded MRI labelling
LivaNova’s latest vagus nerve stimulation (VNS Therapy) system has received US Food and Drug Administration (FDA) approval for expanded magnetic resonance imaging labelling.
According...
Philips to acquire Electrical Geodesics
Royal Philips has announced an agreement to acquire Electrical Geodesics, Inc (EGI), a US-based medical device company that designs, develops and commercialises a range...
MRI selection slows down randomisation but therapy benefit similar to CTP
A subanalysis from the SWIFT PRIME trial has found that time to randomisation was significantly longer in magnetic resonance imaging (MRI)-selected patients in the...
CE mark for full body MR conditional labelling for Proclaim Elite...
The Proclaim Elite spinal cord stimulation (SCS) system (St Jude Medical) has received CE mark approval for full-body magnetic resonance (MR) conditional labelling. With...
Philips to unveil suite of advanced MR-based software applications for assessment...
Royal Philips has announced the introduction of a suite of magnetic resonance (MR)-based software applications dedicated to neurology, which will debut at the Radiological...
Proclaim Elite spinal cord stimulation system earns full-body MRI compatibility labelling
The US Food and Drug Administration (FDA) has approved full-body magnetic resonance (MR) conditional labelling for the Proclaim Elite spinal cord stimulation (SCS) system (St Jude Medical)....
MRI guidance shows promise in delivering stem cell therapies
Working with animals, a team of scientists reports it has delivered stem cells to the brain with unprecedented precision by threading a catheter through...
US FDA clears Icometrix’ image quantification software to monitor neurological disorders
Icometrix has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for their image quantification software, Icobrain. Icobrain is designed to quantify...
Siemens and InSightec sign strategic agreement to develop compatibility between some...
InSightec has signed a strategic agreement with Siemens Healthineers. The strategic collaboration will involve the development of compatibility between Exablate Neuro and Siemens 1.5T...
Boston Scientific receives US FDA approval for Precision Montage MRI spinal...
Boston Scientific Corporation has launched the Precision Montage MRI spinal cord stimulator system after receiving approval from the US Food and Drug Administration (FDA)....
Medtronic offer first complete portfolio of full-body MR conditional neurostimulation systems
The US Food and Drug Administration (FDA) has approved Medtronic’s Specify SureScan MRI surgical leads, which are indicated for use as part of Medtronic...
St. Jude Medical: Returning innovation to chronic pain treatment
With a series of acquisitions and recent product approvals, St. Jude Medical has further solidified its place as a leading provider of treatment options...
St Jude Medical receives CE mark for MRI conditional labelling of...
St Jude Medical has received CE mark approval for magnetic resonance imaging (MRI) conditional labelling for the company’s Prodigy MRI chronic pain system with...
